A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure

PURPOSE: OnabotulinumtoxinA has demonstrated efficacy and safety in the treatment of urinary incontinence (UI) associated with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (OAB); however, real-world evidence is limited. This postmarketing surveillance study aimed to asses...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int Neurourol J
Asıl Yazarlar: Ko, Kwang Jin, Jenkins, Brenda, Patel, Anand, Lee, Kyu-Sung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Continence Society 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449655/
https://ncbi.nlm.nih.gov/pubmed/30943692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1836176.088
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller